Aemetis (AMTX) Stock Price, News & Analysis

Company Overview

Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies USP alcohol and hand sanitizer; and produces renewable natural gas, as well as distilled biodiesel from various vegetable oil and animal waste feedstocks. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies. Aemetis, Inc. is headquartered in Cupertino, California.

Key Stats

• Today's Range: $2.35 to $2.53
• 50-Day Range: $2.21 to $3.95
• 52-Week Range: $2.10 to $7.03
• Volume: 630,646 shs
• Average Volume: 818,690 shs
• Market Capitalization: $105.22 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.95
• Consensus Rating: Moderate Buy

Aemetis Stock Analysis - MarketRank™

Aemetis scored higher than 26% of companies evaluated by MarketBeat, and ranked 226th out of 250 stocks in the oils/energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Aemetis has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Aemetis has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Aemetis are expected to grow in the coming year, from ($2.19) to ($0.55) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Aemetis is -2.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Aemetis is -2.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

14.73% of the outstanding shares of Aemetis have been sold short.

Short Interest Ratio / Days to Cover

Aemetis has a short interest ratio ("days to cover") of 11.1, which indicates bearish sentiment.

Change versus previous month

Short interest in Aemetis has recently increased by 0.31%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Aemetis does not currently pay a dividend.

Dividend Growth

Aemetis does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

14.73% of the outstanding shares of Aemetis have been sold short.

Short Interest Ratio / Days to Cover

Aemetis has a short interest ratio ("days to cover") of 11.1, which indicates bearish sentiment.

Change versus previous month

Short interest in Aemetis has recently increased by 0.31%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: 0.05

News Sentiment

Aemetis has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Oils/Energy companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Aemetis this week, compared to 2 articles on an average week.

Search Interest

Only 5 people have searched for AMTX on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Aemetis insiders have not sold or bought any company stock.

Percentage Held by Insiders

14.34% of the stock of Aemetis is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 27.02% of the stock of Aemetis is held by institutions.

AMTX Stock Analysis - Frequently Asked Questions

How have AMTX shares performed this year?

Aemetis' stock was trading at $5.24 at the beginning of the year. Since then, AMTX shares have decreased by 54.8% and is now trading at $2.37.
View the best growth stocks for 2024 here.

How were Aemetis' earnings last quarter?

Aemetis, Inc. (NASDAQ:AMTX) announced its quarterly earnings results on Thursday, August, 1st. The specialty chemicals company reported ($0.66) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by $0.25. The specialty chemicals company had revenue of $66.56 million for the quarter, compared to analysts' expectations of $75.37 million.

Who are Aemetis' major shareholders?

Top institutional shareholders of Aemetis include Susquehanna Fundamental Investments LLC (0.28%), Bank of New York Mellon Corp (0.23%), Rhumbline Advisers (0.12%) and Hutchinson Capital Management CA (0.05%). Insiders that own company stock include Naomi Louise Boness, John R Block, Andrew B Foster, Timothy Alan Simon and Francis P Barton.
View institutional ownership trends.

How do I buy shares of Aemetis?

Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Aemetis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aemetis investors own include Pennsylvania Real Estate Investment Trust (PEI), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), Tilly's (TLYS), Auxly Cannabis Group (CBWTF) and Novan (NOVN).

Company Calendar

• Last Earnings: 8/01/2024
• Today: 9/20/2024
• Next Earnings (Estimated): 11/14/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Oils/Energy
• Industry: Industrial organic chemicals
• Sub-Industry: Chemicals
• Current Symbol: NASDAQ:AMTX
• CUSIP: N/A
• CIK: 738214
• Web: www.aemetis.com
• Phone: (408) 213-0940
• Fax: 408-252-8044
• Employees: 160
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $12.95
• High Stock Price Target: $28.00
• Low Stock Price Target: $3.50
• Potential Upside/Downside: +446.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.80
• Research Coverage: 5 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($1.17)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-46,420,000.00
• Net Margins: -17.27%
• Pretax Margin: -36.40%
• Return on Equity: N/A
• Return on Assets: -41.58%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.20
• Quick Ratio: 0.11

Sales & Book Value

• Annual Sales: $278.65 million
• Price / Sales: 0.38
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($5.49) per share
• Price / Book: -0.43

Miscellaneous

• Outstanding Shares: 44,398,000
• Free Float: 38,031,000
• Market Cap: $105.22 million
• Optionable: Optionable
• Beta: 1.26